ENVESTNET ASSET MANAGEMENT INC
Position in NTLA — Intellia Therapeutics, Inc.
CIK 1407543
Berwyn, PA
Position in NTLA
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$1,401,097
+$735,586 QoQ
Shares Held
109,290
+47.6% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ENVESTNET ASSET MANAGEMENT INC holds $767,426,760 across 109 Biotechnology names. NTLA ranks #49 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
503,564 | $224,861,468 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,152 | $84,335,201 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
171,797 | $56,842,473 | |
| 4 | INSM |
INSMED Inc
|
299,925 | $49,043,736 | |
| 5 | ARGX |
Argenx SE
|
61,418 | $44,850,494 | |
| 6 | RPRX |
Royalty Pharma plc
|
495,892 | $23,787,939 | |
| 7 | GMAB |
Genmab A/S
|
862,301 | $23,135,535 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
678,518 | $18,794,948 |
All Filings in NTLA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,401,097 | 109,290 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $665,511 | 74,028 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,488,276 | 86,177 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $651,075 | 69,411 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $520,096 | 73,150 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $777,185 | 66,654 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,643,527 | 79,977 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,243,343 | 55,556 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,411,042 | 51,292 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,501,815 | 49,256 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,162,256 | 36,757 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $785,300 | 19,257 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $726,802 | 19,501 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $646,651 | 18,534 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,172,585 | 20,954 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,103,523 | 21,320 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,566,474 | 21,556 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,983,431 | 25,232 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,958,141 | 22,051 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $3,445,768 | 21,282 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $1,817,053 | 22,641 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $839,283 | 15,428 | Shares | Sole | 2021-02-02 | |
| No filing history on record for this holder in this stock. | ||||||